25 May 2013
Keywords: Johnson & Johnson, Janssen-Cilag, Comfyde, Epilepsy, EMEA
Article | 22 January 2010
Janssen-Cilag International NV, a subsidiary of US health care giant Johnson & Johns, has withdrawn its application to the European ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 January 2010
24 May 2013
© 2013 thepharmaletter.com